Graves' disease induced by Alemtuzumab in relapsing-remitting multiple sclerosis patients: an observational study in a reference center. Rodriguez de Vera Gomez P, Garcia-Gonzalez JJ, Rave-Garcia R, Lopez Ruiz R, et al. J Endocrinol Invest 2022 Jun 20. pii: 10.1007/s40618-022-01832.

Read + Share

Amedeo Smart

Independent Medical Education

Rodriguez de Vera Gomez P, Garcia-Gonzalez JJ, Rave-Garcia R, Lopez Ruiz R, et al. Graves' disease induced by Alemtuzumab in relapsing-remitting multiple sclerosis patients: an observational study in a reference center. J Endocrinol Invest 2022 Jun 20. pii: 10.1007/s40618-022-01832.
PMID: 35718853